99.49

1.38% -1.39

Medtronic Plc (MDT)

Überblick Nachrichten Preisverlauf Optionskette Financials Forum Prognose Aktiensplit Dividendenhistorie

Schlusskurs vom Vortag:

$100.88

Offen:

$100.92

24-Stunden-Volumen:

10.35M

Relative Volume:

1.38

Marktkapitalisierung:

$127.55B

Einnahmen:

$34.76B

Nettoeinkommen (Verlust:

$4.79B

KGV:

26.88

EPS:

3.7017

Netto-Cashflow:

$5.21B

1W Leistung:

-3.31%

1M Leistung:

+3.18%

6M Leistung:

+7.08%

1J Leistung:

+7.91%

1-Tages-Spanne:

$99.12

$102.50

1-Wochen-Bereich:

$98.62

$103.62

52-Wochen-Spanne:

$79.55

$106.33

Medtronic Plc Stock (MDT) Company Profile

Firmenname

Medtronic Plc

Sektor

Healthcare (1111)

Branche

Medical Devices (139)

Telefon

01135314381700

Adresse

BUILDING TWO PARKMORE BUSINESS PARK WEST, GALWAY

Mitarbeiter

95,000

Twitter

@Medtronic

Nächster Verdiensttermin

2025-08-19

Neueste SEC-Einreichungen

MDT's Discussions on Twitter

Compare MDT vs ABT, SYK, BSX, EW

Aktien	Preis	Marktkapitalisierung	Umsatz	Nettogewinn	Free Cashflow	ENV
MDT Medtronic Plc	99.49	129.33B	34.76B	4.79B	5.21B	3.7017
ABT Abbott Laboratories	112.68	193.83B	44.33B	6.48B	6.92B	3.7033
SYK Stryker Corp	366.05	140.01B	25.12B	3.25B	4.28B	8.3984
BSX Boston Scientific Corp	74.73	109.92B	20.08B	2.89B	3.82B	1.9391
EW Edwards Lifesciences Corp	75.87	44.36B	6.07B	1.06B	799.60M	1.8527

Medtronic Plc Stock (MDT) Upgrades & Downgrades

Datum	Aktion	Analytiker	Ratingänderung
2026-02-09	Hochstufung	Needham	Hold → Buy
2026-02-03	Fortgesetzt	Citigroup	Buy
2026-01-30	Fortgesetzt	Wells Fargo	Overweight
2026-01-06	Hochstufung	William Blair	Mkt Perform → Outperform
2025-11-19	Hochstufung	Goldman	Sell → Neutral
2025-06-30	Hochstufung	Wolfe Research	Underperform → Peer Perform
2025-06-16	Eingeleitet	Leerink Partners	Outperform
2025-03-04	Hochstufung	Citigroup	Neutral → Buy
2024-10-10	Hochstufung	RBC Capital Mkts	Sector Perform → Outperform
2024-08-21	Bestätigt	Oppenheimer	Perform
2024-08-15	Hochstufung	UBS	Sell → Neutral
2024-08-14	Herabstufung	Stifel	Buy → Hold
2024-05-30	Eingeleitet	Goldman	Sell
2023-07-19	Eingeleitet	Robert W. Baird	Neutral
2023-06-30	Eingeleitet	CL King	Buy
2023-05-30	Hochstufung	Morgan Stanley	Equal-Weight → Overweight
2023-04-24	Hochstufung	Wells Fargo	Equal Weight → Overweight
2023-03-29	Herabstufung	UBS	Buy → Sell
2023-01-09	Herabstufung	RBC Capital Mkts	Outperform → Sector Perform
2022-11-23	Herabstufung	Citigroup	Buy → Neutral
2022-11-23	Herabstufung	Oppenheimer	Outperform → Perform
2022-11-16	Herabstufung	Deutsche Bank	Buy → Hold
2022-10-18	Eingeleitet	Barclays	Equal Weight
2022-10-13	Eingeleitet	Mizuho	Buy
2022-10-12	Eingeleitet	Jefferies	Hold
2022-08-24	Herabstufung	Raymond James	Outperform → Mkt Perform
2022-07-06	Eingeleitet	Wolfe Research	Underperform
2022-06-01	Herabstufung	Atlantic Equities	Overweight → Neutral
2022-05-27	Herabstufung	Needham	Buy → Hold
2022-04-13	Herabstufung	Truist	Buy → Hold
2022-03-02	Fortgesetzt	BofA Securities	Buy
2022-01-10	Herabstufung	BTIG Research	Buy → Neutral
2022-01-07	Herabstufung	Morgan Stanley	Overweight → Equal-Weight
2022-01-04	Herabstufung	Piper Sandler	Overweight → Neutral
2021-12-17	Herabstufung	JP Morgan	Overweight → Neutral
2021-12-16	Herabstufung	Wells Fargo	Overweight → Equal Weight
2021-12-10	Eingeleitet	RBC Capital Mkts	Outperform
2021-06-10	Fortgesetzt	Cowen	Outperform
2021-05-25	Eingeleitet	Barclays	Equal Weight
2021-04-15	Eingeleitet	Atlantic Equities	Overweight
2020-12-15	Hochstufung	Goldman	Sell → Neutral
2020-12-15	Hochstufung	Morgan Stanley	Equal-Weight → Overweight
2020-10-08	Hochstufung	Bernstein	Mkt Perform → Outperform
2020-10-08	Hochstufung	Stifel	Hold → Buy
2020-09-11	Eingeleitet	Wolfe Research	Peer Perform
2020-05-14	Herabstufung	DZ Bank	Buy → Hold
2020-03-30	Herabstufung	Needham	Strong Buy → Buy
2020-03-25	Hochstufung	DZ Bank	Hold → Buy
2020-03-05	Eingeleitet	Citigroup	Buy
2020-02-13	Eingeleitet	Goldman	Sell
2020-01-08	Eingeleitet	SunTrust	Buy
2020-01-02	Hochstufung	Guggenheim	Neutral → Buy
2019-06-05	Hochstufung	Wells Fargo	Market Perform → Outperform
2019-02-04	Bestätigt	Needham	Strong Buy
2019-01-03	Eingeleitet	Deutsche Bank	Buy
2019-01-02	Herabstufung	Citigroup	Buy → Neutral
2018-12-19	Hochstufung	JP Morgan	Neutral → Overweight
2018-11-28	Eingeleitet	UBS	Buy
2018-10-16	Eingeleitet	Barclays	Overweight
2018-08-27	Bestätigt	Argus	Buy

Alle ansehen

Medtronic Plc Aktie (MDT) Neueste Nachrichten

Feb 13, 2026

Stock Market Today, Feb. 13: Inflation Data Steadies Market and Slows AI Disruption Losses - The Motley Fool

Feb 13, 2026

Medtronic receives FDA clearance for Stealth AXiS™ surgical system, first integrated planning, navigation and robotics platform for spine surgery - Orthopedics This Week

Feb 13, 2026

Medtronic Wins FDA Nod For Spine Surgery Tech Designed To Cut Repeat Imaging - Benzinga

Feb 13, 2026

Medtronic (NYSE:MDT) Earns "Overweight" Rating from Barclays - MarketBeat

Feb 13, 2026

Medtronic receives FDA clearance for Stealth Axis(TM) surgical system - marketscreener.com

Feb 13, 2026

Medtronic: Navigating Tariffs And Chinese VBP Challenges (NYSE:MDT) - Seeking Alpha

Feb 13, 2026

Medtronic's Stealth AXiS Surgical System Cleared by FDA for Spine - marketscreener.com

Feb 13, 2026

Needham Upgrades Medtronic (MDT) to Buy, Sets $121 PT on Product Launch Momentum - Finviz

Feb 13, 2026

Medtronic Says FDA Clears Stealth AXiS Surgical System For Robotic Spine Surgery - Nasdaq

Feb 13, 2026

Here Are Friday’s Top Wall Street Analyst Research Calls: Airbnb, AMD, Broadcom, CrowdStrike, Dollar Tree, Medtronic, Pinterest, Rivian, Roku, Tapestry, and More - 24/7 Wall St.

Feb 13, 2026

How To Earn $500 A Month From Medtronic Stock Ahead Of Q3 Earnings - Benzinga

Feb 13, 2026

Medtronic (MDT) Receives Overweight Rating from Barclays with $1 - GuruFocus

Feb 13, 2026

Feb 12, 2026

Peering Into Medtronic PLC's Recent Short Interest - Benzinga

Feb 12, 2026

Wedbush Securities Inc. Grows Position in Medtronic PLC $MDT - MarketBeat

Feb 12, 2026